In China's biotechnology field, InnoModels Biotechnology has made remarkable achievements in drug discovery and development with its leading technology and strong R&D strength. Among them, the company's self-developed PDC high-throughput in vitro drug efficacy platform is rewriting the rules of the game in drug discovery and development with its unique and highly high-throughput and accuracy.
PDC, or Pharmacodynamic Chip, is a new type of drug development technology. It highly simulates drug efficacy by mimicking the drug action mechanism in the human body, so as to quickly and accurately assess the efficacy of drugs in vitro. The high-throughput in vitro drug efficacy platform, on the other hand, realizes high-throughput detection of drug action targets and biomarkers through high-performance liquid chromatography-mass spectrometry (LC-MS) on the basis of PDC.
The PDC high-throughput in vitro drug efficacy platform of InnoModels Biotechnology has the following significant features:
1. High-throughput: the platform can detect multiple drug targets at the same time, which greatly improves the efficiency of drug screening. In one experiment, hundreds of biomarkers can be detected at the same time, making the time and cost of drug development greatly reduced.

2. High accuracy: The LC-MS technology adopted by the platform, with high sensitivity and specificity, can accurately simulate the action of drugs in the human body, effectively avoiding false-positive results in drug development.
3. Highly customizable: the platform can be customized to design experimental protocols according to the needs of customers to meet the demands of different drug development.
4. Wide applicability: the platform can be used not only for new drug R&D, but also for efficacy assessment and mechanism of action studies of known drugs, providing powerful technical support for drug optimization and improvement.
5. Rapid response: the platform can provide experimental results in a short period of time, which accelerates the process of drug development.
In conclusion, the PDC high-throughput in vitro drug efficacy platform of InnoModels Biotechnology is providing unprecedented powerful support for drug discovery and development with its highly high-throughput, accuracy, customization, applicability and rapid response. We have reason to believe that this platform will make greater contributions to human health in the near future.